Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 22, 2021PLoS PathogensOpen Access

Fungal cell wall: An underexploited target for antifungal therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

CIChibuike IbeCMCarol A. Munro

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ibe et al. (2021) studied this question.

synapsesocial.com/papers/6a704d98fe4101aa97e019c9https://doi.org/10.1371/journal.ppat.1009470
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Architecture of the Yeast Cell Wall1997 · 644 citations
  2. 2Efficacy of the Anti‐<i>Candida</i>rAls3p‐N or rAls1p‐N Vaccines against Disseminated and Mucosal Candidiasis2006 · 181 citations
  3. 3Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations2013 · 787 citations
  4. 4Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using an <i>In Vivo</i> Murine Invasive Candidiasis Model2014 · 94 citations
  5. 5<i>In Vitro</i> Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods2012 · 96 citations